faculty photo

Judith B. Grinspan, Ph.D.

Research Professor of Neurology
Mahoney Institute for Neurological Science, University of Pennsylvania
Institute for Regenerative Medicine-program in nervous system development and repair, University of Pennsylvania
Department: Neurology

Contact information
Children’s Hospital of Philadelphia
516D Abramson Center
Philadelphia, PA 19104
Office: (215) 590-2094
Fax: (215) 590-3709
Lab: (215) 590-5179
Education:
A.B. (Biology)
Vassar College , 1974.
M.S. (Pathology)
Hahnemann University (now Drexel University), 1977.
Ph.D. (Biology)
University of Pennsylvania, 1984.
Post-Graduate Training
Teaching Fellow, University of Pennsylvania, 1977-1979.
Predoctoral Fellow, Wistar Institute (NIH Training Grant), 1979-1984.
Postdoctoral Fellow, Children's Hospital of Philadelphia (NIH Training Grant), 1984-1986.
National Multiple Sclerosis Society Research Postdoctoral Fellow, Children's Hospital of Philadelphia, 1986-1989.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Research Interests
Our lab studies factors that control the maturation of oligodendrocytes, the myelinating cells of the central nervous system, from stem cells through to myelination.

Key words: oligodendrocytes, myelin, growth factors, oxidative stress, neuroinflammation, MS, HIV.

Description of Research
In the central nervous system, oligodendrocytes synthesize myelin as an extension of their plasma membranes. This myelin wraps axons and facilitates rapid and efficient conduction of nervous impulses as well as axonal nourishment and protection. Destruction of myelin through injury, such as birth injury leading to cerebral palsy, or disease, such as multiple sclerosis or HIV, causes loss of motor and cognitive function. Oligodendrocyte precursors and stem cells remain in the CNS following the pathology and are potentially capable of forming mature oligodendrocytes and then myelin. However, their maturation is severely limited. Reasons for this include processes such as oxidative stress and inflammation which signal to inhibitors present in the area that impede maturation. Our goal is to identify factors in the CNS that inhibit the development of mature oligodendrocytes both during development and disease. We have identified several key signaling factors that regulate developmental myelination and are increased during demyelinating disease. On-going areas of investigation in the lab include: 1) The role of white matter loss and demyelination in HIV-associated neurocognitive deficits. 2) Factors which limit myelination in perinatal white matter injury. 3) The role of lipid signaling in developmental myelination and remyelination following demyelinating disease.


Lab personnel:
Micah Romer research assistant
Bassam Zidane, graduate student
Lindsay Roth, graduate student

Selected Publications

Monnerie, H., Romer, M., Jensen, B., Millar, J., Jordan-Sciutto, K., Kim, S.F., Grinspan, J.B.: Reduced Sterol Regulatory Element-Binding Protein (SREBP) Processing through Site-1 Protease (S1P) Inhibition Alters Oligodendrocyte differentiation In Vitro. J. Neurochem. 140(1): 53-67, Jan 2017.

Jensen, B.K., Monnerie, H., Mannell, M.V., Gannon, P.J., Espinoza-Akay, C., Erickson, M.A., Bruce-Keller, A.J., Gelman, B.B., Briand, L.A., R. Pierce, R.C., Jordan-Sciutto, K.L., Grinspan, J.B. : Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Anti-Retrovirals in HIV-Associated Neurocognitive Disorders. Journal of Neuropathology Experimental Neurology 74(11): 1093-1118, Nov 2015.

Veasey, S.C., Lear, J., Zhu, Y.,Grinspan, J. B., Hare, D.J., Wang, S., Bunch,D., Lim, D.C., Doble, P.A., Robinson, S.R.: Long-term Intermittent Hypoxia Elevates Cobalt Levels in the Brain and Injures White Matter in Adult Mice. Sleep 36: 1471-1481, 2013.

Reid, M.V., Murray, K. A., Marsh, E.D., Golden, J. A., Simmons, R.A., Grinspan, J. B.: Delayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating BMP4. Journal of Neuropathology Experimental Neurology 71(7): 640-653, 2012.

Feigenson, K., Reid, M., See, J., Crenshaw, E.B. III, Grinspan, J. B. : Canonical Wnt signaling requires the BMP pathway to inhibit oligodendrocyte maturation. ASN NEURO 3: 147-158, 2011.

French, H. M., Reid, M., Mamontov, P., Simmons, R. A., Grinspan, J. B.: Oxidative stress disrupts oligodendrocyte maturation. Journal of Neuroscience Research 87: 3076-3087, 2009.

Feigenson, K., Reid, M., See, J., Crenshaw E.B. III, Grinspan, J. B.: Wnt signaling is sufficient to perturb oligodendrocyte maturation. Molecular and Cellular Neuroscience 42: 255-265, 2009.

Ara, J., See, J., Mamontov, P., Hahn, A., Bannerman, P. Pleasure, D., Grinspan, J.B.: Bone morphogenetic proteins 4, 6, and7 are upregulated in mouse spinal cord during experimental autoimmune encephalomyelitis. Journal of Neuroscience Research 86: 125-135, 2008.

See, J., Mamontov, P., Ahn K., Wine-Lee, L., Crenshaw III, E.B., Grinspan, J. B.: BMP mutant mice exhibit glial cell maturation defects. Molecular and Cellular Neuroscience 35: 171-182, 2007.

See, J., Zhang, X., Eraydin, N. Mun, S.B., Mamontov, P., Golden, J. Grinspan, J.B.: Oligodendrocyte maturation is inhibited by bone morphogenetic protein. Molecular and Cellular Neuroscience 26: 481-492, 2004.

back to top
Last updated: 11/13/2024
The Trustees of the University of Pennsylvania